HemaSphere
(Aug 2023)
P1089: ZANUBRUTINIB-RITUXIMAB CHEMO-FREE THERAPY WITH OR WITHOUT AUTOLOGOUS STEM CELL TRANSPLANTATION IN NEWLY DIAGNOSED MANTLE CELL LYMPHOMA
- Chang-Ju Qu,
- Rui Zou,
- Jia-Jie He,
- Na-Na Ping,
- Qian Zhu,
- Xiao Zhang,
- Fan Xia,
- Danqing Kong,
- De-Pei Wu,
- Zheng-Ming Jin
Affiliations
- Chang-Ju Qu
- 1 The First Affiliated Hospital of Soochow University, Department of Hematology, Suzhou, China
- Rui Zou
- 2 The First Affiliated Hospital of Soochow University, Department of Pharmacy, Suzhou, China
- Jia-Jie He
- 1 The First Affiliated Hospital of Soochow University, Department of Hematology, Suzhou, China
- Na-Na Ping
- 1 The First Affiliated Hospital of Soochow University, Department of Hematology, Suzhou, China
- Qian Zhu
- 1 The First Affiliated Hospital of Soochow University, Department of Hematology, Suzhou, China
- Xiao Zhang
- 1 The First Affiliated Hospital of Soochow University, Department of Hematology, Suzhou, China
- Fan Xia
- 2 The First Affiliated Hospital of Soochow University, Department of Pharmacy, Suzhou, China
- Danqing Kong
- 1 The First Affiliated Hospital of Soochow University, Department of Hematology, Suzhou, China
- De-Pei Wu
- 1 The First Affiliated Hospital of Soochow University, Department of Hematology, Suzhou, China
- Zheng-Ming Jin
- 1 The First Affiliated Hospital of Soochow University, Department of Hematology, Suzhou, China
- DOI
-
https://doi.org/10.1097/01.HS9.0000971252.93458.20
- Journal volume & issue
-
Vol. 7
p.
e9345820
WeChat QR code